Erasca (ERAS) Reiterated at Buy by Stifel After Annual Stifel Summer Biotech Summit

August 17, 2026 7:07 AM

Stifel analyst Laura Prendergast reiterated a Buy rating and $30.00 price target on Erasca Inc (NASDAQ: ERAS).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found